RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
Clinical trial NCT02871843 · COMPLETED
Trial details
- NCT number
- NCT02871843
- Sponsor
- EpicentRx, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-14
- Primary completion
- 2019-10-11
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.